Categories
Shukra Pharmaceuticals Ltd — Board Meeting, 07-05-2026: Board Meeting
07-05-2026 · 10:22 pm
Shukra Pharma's Board approved Q4/FY26 financial results & proposed a ₹0.01 dividend. It allotted 17.35 lakh shares to promoters for ₹4.42 Cr via warrant conversion, raising paid-up capital from ₹43.79 Cr to ₹43.96 Cr. 29.08 lakh warrants remain.
No comments yet. Be the first to comment!